Sven Ante Lundberg Crispr Therapeutics Ag (CRSP) insider trading activity

Sven Ante Lundberg is Chief Scientific Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 505,217 shares of CRSP, which is worth approximately $27.6 Million. The most recent transaction as insider was on Oct 24, 2016, when has been sold 55,217 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 505K

0% 3M change

0% 12M change

Total Value Held $27.6 Million

Sven Ante Lundberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 24 2016	BUY Conversion of derivative security	-	55,217 Added 9.85%	505,217 Common Shares

Also insider at

VOR

Vor Biopharma Inc. Healthcare

MRUS

Merus N.V. Healthcare

President, CEO & PEO

FIXX

Homology Medicines, Inc. Healthcare

SAL